Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Raises $4.3M to Commercialize ISB s Genetic Analysis Technology

NEW YORK, Aug. 11 (GenomeWeb News) - NanoString Technologies said today that it has secured $4.3 million in an investment round led by OVP Venture Partners and Draper Fisher Jurvetson.

 

NanoString said it plans to use the funding to accelerate development of its technology platform, a single-molecule bar-coding system developed at the Institute for Systems Biology for use in gene expression analysis.

 

NanoString has an exclusive license with ISB for rights to the technology, which was developed by Krassen Dimitrov, chief scientific officer of NanoString and former director of microarrays at ISB. The company said it anticipates the technology to be as much as 100,000 times more sensitive than a DNA microarray.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.